Genmab
GMAB
#588
Rank
$29.54 B
Marketcap
$44.35
Share price
-1.07%
Change (1 day)
13.20%
Change (1 year)

Earnings for Genmab (GMAB)

Earnings in 2022 (TTM): $1.02 B

According to Genmab's latest financial reports the company's current earnings (TTM) are $1.02 B. In 2021 the company made an earning of $0.62 B a decrease over its 2020 earnings that were of $0.90 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genmab from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$1.02 B64.19%
2021$0.62 B-31.09%
2020$0.90 B111.53%
2019$0.42 B69.43%
2018$0.25 B49.63%
2017$0.16 B3.27%
2016$0.16 B46.33%
2015$0.11 B117.13%
2014$51.28 M329.17%
2013$11.94 M-159.26%
2012-$20.17 M-48.96%
2011-$39.51 M90.86%
2010-$20.7 M-67.46%
2009-$63.62 M